BiotechTube
Home/Pipeline/ELGN-GI

ELGN-GI

Gastrointestinal maturation in preterm infants

Phase 3Active

Key Facts

Indication
Gastrointestinal maturation in preterm infants
Phase
Phase 3
Status
Active
Company
Elgan Pharma

About Elgan Pharma

Israeli biotech developing non‑invasive, organ‑targeted therapies for preterm infants with unmet clinical needs.

View full company profile

Therapeutic Areas

NeonatologyGastroenterologyOphthalmology